FIELD: medicine, traumatology.
SUBSTANCE: the suggested biotransplant is being the suspension of chondroprogenitor cells obtained out of hyaline cartilage of human embryos of 1st -2nd trimester of pregnancy, due to mechanical and fermentative disaggregation followed by cultivating cellular suspension upon selective culture medium in the presence of embryonic bovine serum being homogenous cell culture at the content of aggrecane- and collagen II-expressing cells being 80%, not less and viable cell - 90%, not less to be applied for treating degenerative and traumatic diseases of motor system at no undesirable side effects.
EFFECT: higher efficiency of therapy.
5 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CULTURE OF GENETICALLY NON-MODIFIED HUMAN CHONDROPROGENITORY CELLS AND METHOD FOR THEIR PREPARING | 2003 |
|
RU2242980C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING PARODONTIUM DISEASES | 2004 |
|
RU2265445C1 |
| BIOTRANSPLANT FOR TREATMENT OF DEGENERATIVE AND TRAUMATIC DISEASE OF CARTILAGE TISSUE AND METHOD FOR ITS PREPARING | 2005 |
|
RU2301677C1 |
| BIOTRANSPLANT FOR JOINTS CARTILAGINOUS TISSUE DEFECTS RESTORING | 2015 |
|
RU2593011C1 |
| METHOD FOR PRODUCING DONOR CHONDROCYTES | 2009 |
|
RU2409662C2 |
| FGF-18 IN TRANSPLANTATION AND TISSUE ENGINEERING PROCEDURES | 2015 |
|
RU2682159C2 |
| HYALINE CARTILAGE REPAIR METHOD IN TREATMENT OF INTRAARTICULAR FRACTURES | 2008 |
|
RU2364360C1 |
| IMPLANT CONTAINING FGF-18 | 2015 |
|
RU2700414C2 |
| METHOD FOR SUBSTITUTION OF CARTILAGINOUS TISSUE DEFECTS | 2016 |
|
RU2637103C2 |
| METHOD OF BIOFABRICATION OF A TRANSPLANT IN THE FORM OF CELL SPHEROIDS FOR REGENERATIVE TECHNOLOGIES FOR RESTORING A SUBJECT'S CARTILAGE BASED ON THE SUBJECT'S OWN COSTAL CARTILAGE PERICHONDRIUM AND MULTIPOTENT MESENCHYMAL STROMAL BONE MARROW CELLS OF THE SAME SUBJECT | 2022 |
|
RU2800991C2 |
